Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma

Tumori

Volumn 87, Issue 1, 2001, Pages 14-17

  Airoldi, M ^a   Gabriele, A M ^a   Gabriele, P ^a   Pedani, F ^a   Marchionatti, S ^a   Succo, G ^a   Beatrice, F ^a   Bumma, C ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Parotid gland; Radiation therapy; Salivary gland tumor

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PAROTID GLAND CARCINOMA; PROGNOSIS; RADIATION DOSE; SALIVARY GLAND TUMOR; SIDE EFFECT; TREATMENT PLANNING; UNDIFFERENTIATED CARCINOMA;

EID: 0035056739     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700103     Document Type: Article

References (27)

1. Salivary gland tumors
2. Aggressive surgery in treatment for parotid cancer. The role of adjunctive postoperative radiotherapy
3. Major salivary gland tumors
4. Salivary glands
5. The role of radiation therapy in treatment of parotid carcinoma
6. Carcinoma of the major salivary glands
7. The role of fast neutron radiation therapy in the management of advanced salivary gland malignant neoplasms
8. The implications of improved treatment of malignant salivary gland tumors by fast neutron radiotherapy
9. Fast neutron radiation for inoperable and recurrent salivary gland cancers
10. Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized trial
11. Brachytherapy for malignant tumors of salivary gland origin
12. Carcinoma of the major and minor salivary glands. Analysis of treatment results and sites and causes of failure
13. Salivary neoplams-radiation therapy
14. Photon irradiation of unresectable carcinomas of salivary glands
15. Chemotherapy for recurrent salivary gland malignancies: Experience of the ENT Department of Turin University
16. Cisplatin, epirubicin and 5-fluorouracil combination chemotherapy for recurrent carcinoma of the salivary gland
17. Vinorelbine for recurrent adenocarcinoma-like salivary gland malignancies
18. Paclitaxel + carboplatin in recurrent salivary gland malignancies
19. Cisplatin + vinorelbine vs vinorelbine alone in recurrent salivary gland malignancies: A randomized trial
20. A phase III comparison of standard radiation therapy versus RT plus concurrent cisplatin versus split-course RT plus concurrent DDP and 5-fluorouracil in patients with unresectable squamous cell head and neck cancer: An Intergroup Study
21. Chemo-radiotherapy vs radiotherapy in patients with advanced nasopharyngeal cancer: Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) phase III study: Progress report
22. Meta-analysis of chemotherapy in head and neck cancer: Loco-regional treatment vs same treatment + chemotherapy
23. Hyperthermia and radiation therapy for inoperable or recurrent parotid carcinoma
24. Phase II trial of VP-16, bleomycin, and cisplatin in patients with advanced nonsquamous cell head and neck neoplasms
25. A long-term assessment of adjuvant chemotherapy on outcome of patients with extra-capsular spread of cervical metastases from squamous carcinoma of the head and neck
26. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck
27. Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer